🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Izokibep is a small protein molecule that acts as a selective, potent inhib...
Status
Terminated
Location
Clinical Research Site
Start Date
2022-08-23
Trial ID
NCT05384249
Izokibep is a potent and selective inhibitor of interleukin 17A (IL-17A) th...
Status
Completed
Location
Clinical Research Site
Start Date
2022-05-05
Trial ID
NCT05355805
Treatments Being Tested
Izokibep is a small protein molecule that acts as a selective, potent inhib...
Status
Terminated
Location
Clinical Research Site
Start Date
2023-06-22
Trial ID
NCT05905783
This is a multicenter, phase 2 trial to explore the efficacy and safety of ...
Status
Completed
Location
Research Site
Start Date
2022-01-06
Trial ID
NCT04706741
Treatments Being Tested
ABY-035-204 is a clinical study to assess the efficacy of IL-17 blocker ABY...
Status
Terminated
Location
Arizona Arthritis & Rheumatology Research, PLLC
Start Date
2021-08-24
Trial ID
NCT04795141
Izokibep is a potent and selective inhibitor of interleukin (IL)-17A that i...
Status
Terminated
Location
Clinical Research Site
Start Date
2022-11-21
Trial ID
NCT05623345
Treatments Being Tested